HIGHLIGHTS
- who: Zufar Safiullov et al. from the The Department of Histology, Cytology and Embryology, Kazan State Medical University, Kazan, Russia have published the research: Autologous Genetically Enriched Leucoconcentrate in the Preventive and Acute Phases of Stroke Treatment in a Mini-Pig Model, in the Journal: Pharmaceutics 2022, 2209 of 26/05/2020
- what: The authors propose a proof of concept for the use of an leucoconcentrate temporally secreting recombinant vascular endothelial growth factor (VEGF) glial-cell-line-derived neurotrophic factor (GDNF) and the neural cell adhesion molecule (NCAM) for the treatment of stroke. In this . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.